Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
Authors
Keywords
Diabetes mellitus, Heart failure, Incretin modulating drugs, GLP-1 analogues, DPP-4 inhibitors
Journal
HEART FAILURE REVIEWS
Volume 18, Issue 2, Pages 141-148
Publisher
Springer Nature
Online
2012-05-08
DOI
10.1007/s10741-012-9318-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
- (2011) Robert Ratner et al. Cardiovascular Diabetology
- A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans
- (2011) Philip A. Read et al. Circulation-Cardiovascular Interventions
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Management of type 2 diabetes: new and future developments in treatment
- (2011) Abd A Tahrani et al. LANCET
- Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
- (2010) Mads Halbirk et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38α MAP Kinase–Mediated, Nitric Oxide–Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy
- (2010) Siva Bhashyam et al. Circulation-Heart Failure
- Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired -Cell Function?
- (2010) J. J. Meier et al. DIABETES
- DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
- (2010) J. B. Buse et al. DIABETES CARE
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
- (2010) M. Komajda et al. EUROPEAN HEART JOURNAL
- Glucose and Insulin Abnormalities in Patients with Heart Failure
- (2010) Christi Deaton et al. European Journal of Cardiovascular Nursing
- Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease
- (2010) R. M. Beadle et al. HEART
- Impaired Glucose Tolerance and Insulin Resistance in Heart Failure: Underrecognized and Undertreated?
- (2010) Mamas A. Mamas et al. JOURNAL OF CARDIAC FAILURE
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
- (2009) David M. Kendall et al. AMERICAN JOURNAL OF MEDICINE
- A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
- (2009) Enrique Z Fisman et al. Cardiovascular Diabetology
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone Rat
- (2008) Indu Poornima et al. Circulation-Heart Failure
- The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions
- (2008) J. Girard DIABETES & METABOLISM
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Diabetes, left ventricular systolic dysfunction, and chronic heart failure
- (2008) Michael R. MacDonald et al. EUROPEAN HEART JOURNAL
- Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
- (2008) Luc F Van Gaal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now